Clinical evaluation for the efficacy, safety, tolerability and medical resource utilization of Invanz (ertapenem sodium) therapy
Phase of Trial: Phase III
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Sponsors Merck & Co
- 01 Feb 2007 Status changed from recruiting.
- 25 Nov 2006 New trial record.